Assessment of a sustained release capsule and a tablet formulation of theophylline
Newth, C.J.; Isles, A.F.
British Journal of Clinical Practice. Suppl 35: 53-54
1984
ISSN/ISBN: 0262-8767 PMID: 6433961 Document Number: 230082
Document emailed within 1 workday
Related Documents
Winsemius, A.; Meuwsen, I.M.; Boon, C.; van der Laan, A.; Brekle, A.; de Vries, M. 2002: A pharmacokinetic comparison of the modified release capsule and a plain tablet formulation of mebeverine International Journal of Clinical Practice 56(9): 659-662Jonkman, J.H.; van der Boon, W.J.; Schoenmaker, R.; Holtkamp, A.; Thürkow-Luikens, A.J. 1984: The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 506-510
Ferrari, M.; Olivieri, M.; Romito, D.; Biasin, C.; Barozzi, E.; Bassetti, S. 1991: Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline Rivista Europea Per le Scienze Mediche e Farmacologiche 13(5-6): 269-274
Harrison, L.I.; French, I.W.; Mildon, C.A. 1982: Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans Clinical Therapeutics 4(6): 489-496
Linares Borges, A.; Rodríguez Muñiz, J.M.; Alemán Aguilar, H.; Yamir Betancourt, B.; Jiménez Hernández, L.; Chala Tandrón, J.M.; Martín García, L.M.; de la Vega Elías, L. 2000: Clinical effect of a sustained-release theophylline formulation in moderate or severe asthmatic patients with intercrisis Revista Alergia Mexico 47(2): 65-69
Ayanoglu, G.; Witte, P.U.; Badian, M. 1983: Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil) International Journal of Clinical Pharmacology Therapy and Toxicology 21(9): 479-482
Steinijans, V.W.; Trautmann, H.; Sauter, R.; Staudinger, H. 1988: Theophylline therapeutic drug monitoring in the case of a new sustained-release pellet formulation for once-daily evening administration Arzneimittel-Forschung 38(8a): 1251-1253
Weiss, G.; Klemm, F.H.; Fuchs, W.S.; Stanislaus, F.; Zema, M.; Calanchi, M. 1998: Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension Arzneimittel-Forschung 48(5a): 604-612
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
McIntosh, D. 1971: A comparative assessment of choline theophyllinate and sustained-release theophylline in patients attending a chest clinic British Journal of Clinical Practice 25(5): 233-235
Rachelefsky, G.S.; Katz, R.M.; Siegel, S.C. 1978: A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels Annals of Allergy 40(4): 252-257
Zhang, Y.; Huang, G.; Yu, Y.; Han, J.; Yu, P. 2006: Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 23(3): 597-600; 614
Jin, M.; Guo, Q.; Sun, X.; Zhang, X.; Lv, Y.; Xiao, W. 2011: Pharmacokinetics of ginkgolides sustained-release tablet Zhongguo Zhong Yao Za Zhi 36(8): 1011-1014
Regmi, B.M.; Liu, J.P.; Tu, X.D. 1996: Studies on ethmozine sustained-release tablet remaining-floating in stomach Yao Xue Xue Bao 31(1): 54-58
Cleophas, T.J.; Niemeyer, M.G.; Zwinderman, A.H.; van der Wall, E.E. 2000: Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group Angiology 51(8): 631-638
Mellstrand, T.; Svedmyr, N.; Fagerström, P.O. 1980: Absorption of theophylline from conventional and sustained-release tablets European Journal of Respiratory Diseases. Supplement 109: 54-60
Buri, P.; Doelker, E. 1980: Formulation of sustained-release tablets. II. Hydrophilic matrices Pharmaceutica Acta Helvetiae 55(7-8): 189-197
Araico, A.; Saadeddin, A.; Torres-Molina, F.; Peris, J.E. 2009: In vivo evaluation of a new sustained-release formulation of morphine Die Pharmazie 64(10): 653-655
Rey, H.; Wagner, K.G.; Wehrlé, P.; Schmidt, P.C. 2000: Development of matrix-based theophylline sustained-release microtablets Drug Development and Industrial Pharmacy 26(1): 21-26
Ritschel, W.A.; Koch, H.P.; Alcorn, G.J. 1984: In vivo-in vitro correlations with sustained-release theophylline preparations Methods and Findings in Experimental and Clinical Pharmacology 6(10): 609-618